Evidence map›Paper›PMID 35467499›Full record

ArticleMicrobiology (Reading, England)2022

Inhibition of

Brad A Haubrich, Saman Nayyab, Mika Gallati, Jazmeen Hernandez, Caroline Williams, Andrew Whitman, Tahl Zimmerman, Qiong Li, Yuxing Chen, Cong-Zhao Zhou and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology (Reading, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Brad A HaubrichCenter for Health and Behavioral Sciences, Department of Science and Technology, Bryant University, 1150 Douglas Pike, Smithfield, RI 02917, USA.
Saman NayyabCenter for Health and Behavioral Sciences, Department of Science and Technology, Bryant University, 1150 Douglas Pike, Smithfield, RI 02917, USA.
Mika GallatiCenter for Health and Behavioral Sciences, Department of Science and Technology, Bryant University, 1150 Douglas Pike, Smithfield, RI 02917, USA.
Jazmeen HernandezCenter for Health and Behavioral Sciences, Department of Science and Technology, Bryant University, 1150 Douglas Pike, Smithfield, RI 02917, USA.
Caroline WilliamsCenter for Health and Behavioral Sciences, Department of Science and Technology, Bryant University, 1150 Douglas Pike, Smithfield, RI 02917, USA.
Andrew WhitmanCenter for Health and Behavioral Sciences, Department of Science and Technology, Bryant University, 1150 Douglas Pike, Smithfield, RI 02917, USA.
Tahl ZimmermanDepartment of Family and Consumer Sciences, North Carolina A&T State University, Greensboro, NC, USA.
Qiong LiSchool of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027, PR China.
Yuxing ChenSchool of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027, PR China.
Cong-Zhao ZhouSchool of Life Sciences, University of Science and Technology of China, Hefei, Anhui, 230027, PR China.
Amit BasuDepartment of Chemistry, Brown University, Providence, RI, USA.
Christopher W ReidCenter for Health and Behavioral Sciences, Department of Science and Technology, Bryant University, 1150 Douglas Pike, Smithfield, RI 02917, USA.
Bryant University · USUniversity of Science and Technology of China · CNBrown University · USNorth Carolina Agricultural and Technical State University · US

Funding

Training CoreP20GM103430 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI Bongsup P Cho · 2012 to 2026
$63.6M
Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
NIGMS NIH HHS P20 GM103430NIGMS NIH HHS R24 GM137786
6 · The paper itself

Abstract

Despite renewed interest, development of chemical biology methods to study peptidoglycan metabolism has lagged in comparison to the glycobiology field in general. To address this, a panel of diamides were screened against the Gram-positive bacterium

Indexed as

PeptidoglycanStreptococcus pneumoniaeAnti-Bacterial AgentsCell WallDiamideN-Acetylmuramoyl-L-alanine AmidaseAnti-Bacterial AgentsDiamideN-Acetylmuramoyl-L-alanine AmidasePeptidoglycancell wallchemical biologymeta-phenotypemode-of-actionpeptidoglycan

Identifiers

PMID35467499
PMCPMC10233265
OpenAlexW4224441985

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.